VivoSeq
Other

Ciprofloxacin

0

Pipeline Programs↗

3

Active Trials↗

11

Companies Involved↗

Ciprofloxacin is an early-stage landscape with 0 programs across 11 companies. The most active players are Mylan Pharmaceuticals Inc, Bayer, NeuroSense Therapeutics Ltd..

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Mylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalN

NeuroSense Therapeutics Ltd.

0 programs

PreclinicalM

MerLion Pharmaceuticals GmbH

0 programs

PreclinicalE

Elusys Therapeutics

0 programs

PreclinicalM

Mutual Pharmaceutical Company, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

32

clinical trials

Completed25 · 78%
Terminated2 · 6%
Suspended1 · 3%
Active, not recruiting1 · 3%
Recruiting1 · 3%
Unknown status1 · 3%
Other1 · 3%

Clinical Trials

Trial Activity

32 trials

SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
Recruiting·UUniversity of Washington·N/A·NCT05286931·1,800 enrolled
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)
Active, not recruiting·UUniversity College, London·N/A·NCT04678869·313 enrolled
Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients.
Not yet recruiting·VVersailles Hospital·Phase 3·NCT07483736·1,526 enrolled
Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery
Completed·OOxford University Clinical Research Unit, Vietnam·Phase 4·NCT03854929·364 enrolled
Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
Completed·Mylan Pharmaceuticals Inc logoMylan Pharmaceuticals Inc·Phase 1·NCT00649662·36 enrolled
Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)
Completed·MMerLion Pharmaceuticals GmbH·Phase 2·NCT00722735·36 enrolled
Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia
Completed·—·Phase 4·NCT04456712·200 enrolled
Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
Completed·HHelsinn Healthcare SA·Phase 1·NCT02118909·32 enrolled
Ciprofloxacin on Burned Patients
Completed·Bayer logoBayer·Phase 3·NCT00668044·18 enrolled
Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers
Completed·EElusys Therapeutics·Phase 1·NCT01952444·40 enrolled
Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT02961751·211 enrolled
Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
Completed·Bayer logoBayer·N/A·NCT02661438·46 enrolled
Impact of Formulation on Ciprofloxacin Oral Absorption
Completed·UUniversity of Maryland, Baltimore·Phase 1·NCT00992329·16 enrolled
Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy
Completed·FFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia·Phase 4·NCT01803191·461 enrolled
Ciprofloxacin Multiple Dose for Adult Cholera
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT00741052·218 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)